Arnaud Rosier, CEO of Implicity
As healthcare continues its shift toward value-based, patient-centered care, remote monitoring (RM) has become a cornerstone in the management of chronic cardiac conditions. For patients with implantable cardioverter-defibrillators (ICDs) and…
Continue Reading
What You Should Know:
– Philips has unveiled new findings from its Future Health Index 2025: Cardiology Snapshot, a report that explores how cardiac care professionals and patients view the role of AI and digital…
Continue Reading
What You Should Know:
– GE HealthCare announced the launch of the Vivid™ Pioneer, an advanced and adaptive cardiovascular ultrasound system. The system, which recently received CE Mark and U.S. FDA 510(k) clearance, is designed…
Continue Reading
What You Should Know:
– HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced its U.S. commercial launch.
– HeartFocus will initially be available on Butterfly Network’s handheld ultrasound devices, the FDA-cleared…
Continue Reading
Dr. Jerome Adams, Former U.S. Surgeon General
What You Should Know:
– Eko Health, a company specializing in AI-powered cardiac and pulmonary detection, has announced that Dr. Jerome Adams, former U.S. Surgeon General, has…
Continue Reading
Jakob Wollborn, M.D., M.P.H., Cardiothoracic Anesthesiologist and Intensivist at Brigham and Women’s Hospital
Atrial fibrillation, or AFib, is one of the most common complications following cardiac surgery. It affects up to 40% of patients, depending…
Continue Reading
The National Institute for Health and Care Excellence (NICE) has conditionally recommended six digital platforms for use in the NHS, which will enable people with heart disease to complete their recovery sessions at home.
Draft…
What You Should Know:
– United Healthcare has updated its cardiac imaging guidelines to align with recommendations from radiology benefit manager EviCore, announcing new coverage for coronary computed tomography angiography (CTA) plaque quantification.
– The new…
Continue Reading
Ultromics, a provider of AI-driven cardiology solutions, has raised $55 million (£41m) in Series C financing to scale its technology across the US.
Founded out of the University of Oxford, Ultromics offers the first FDA-cleared…
Series C Funding Overview
Healthcare artificial intelligence startup Ultromics has successfully secured $55 million in Series C funding, marking a significant milestone in the medical AI industry. This substantial investment round demonstrates growing investor confidence…
